Safety of Autologous M2 Macrophage in Treatment of Non-Acute Stroke Patients


Phase 1 Results N/A

Summary of Purpose

The purpose of this study is to determine whether M2 macrophages are safe and feasible in the treatment of non-acute stroke patients

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 29 April 2013.

1 Oct 2012 24 Apr 2013 1 Apr 2014 1 Oct 2015 1 Apr 2013 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Masking: Open Label
  • Purpose: Treatment
  • Endpoint: Safety Study
  • Intervention: Single Group Assignment